| Identification | Back Directory | [Name]
1H-Indole-6-carbonitrile, 3-[2-[[(2α,3aS,5α,6aR)-5-aminooctahydro-2-pentalenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]-7-(dimethylphosphinyl)-, rel- | [CAS]
2765676-60-4 | [Synonyms]
CDK7-IN-17
1H-Indole-6-carbonitrile, 3-[2-[[(2α,3aS,5α,6aR)-5-aminooctahydro-2-pentalenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]-7-(dimethylphosphinyl)-, rel- | [Molecular Formula]
C24H26F3N6OP | [MOL File]
2765676-60-4.mol | [Molecular Weight]
502.48 |
| Hazard Information | Back Directory | [Uses]
CDK7-IN-17 is a potent inhibitor of CDK7. CDK7-IN-17 is a pyrimidinyl derivative compound. CDK7-IN-17 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1]. | [References]
[1] Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A. |
|
|